Development, validation, and results of a risk-standardized measure of hospital 30-day mortality for patients with exacerbation of chronic obstructive pulmonary disease.

BACKGROUND Despite its large clinical and economic significance, measuring and improving the outcomes of patients hospitalized for chronic obstructive pulmonary disease (COPD) is only beginning to emerge as a national priority for policy makers and payers. OBJECTIVE To facilitate the public reporting of hospital outcomes, we developed a risk-standardized measure of hospital 30-day mortality for patients admitted with exacerbation of COPD. DESIGN Hierarchical logistic regression model. SETTING/PATIENTS Medicare Part A and Part B claims in a random sample of half of all admissions for patients admitted to acute care hospitals in 2008 (development cohort) and remaining 2008 admissions (validation cohort). We also assessed model performance and predictive ability in 2007 and 2009 data. MEASUREMENTS Hospital risk-standardized 30-day mortality rates. RESULTS The model development sample consisted of 150,035 admissions at 4537 nonfederal acute care US hospitals, with a mean unadjusted hospital 30-day mortality rate of 8.6%. The mean risk-standardized mortality rate was 8.6% and ranged from 5.9% to 13.5%. The development and validation models had good discrimination (areas under the receiver operating characteristic curve 0.72 and 0.72, respectively) and predictive ability (predicted mortality at the 1st and 10th deciles 1.5%, 23.7%, and 1.6%, 23.8%, respectively) and showed no evidence of over-fitting. CONCLUSIONS A 30-day mortality model based on administrative claims had similar discrimination to other public reporting models and can be used to compare risk-adjusted outcomes for patients with exacerbations of COPD and to track changes in outcomes over time. The high mortality and variation in rates across institutions suggest opportunities to improve quality of care.

[1]  Randall P. Ellis,et al.  Diagnostic cost group hierarchical condition category models for medicare risk adjustment , 2000 .

[2]  Xiaowu Sun,et al.  Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. , 2009, Archives of internal medicine.

[3]  D. Bratzler,et al.  Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: physician practices in the community hospital setting. , 2004, The Journal of the Oklahoma State Medical Association.

[4]  J. Skinner,et al.  Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. , 2011, JAMA.

[5]  Robert Harbaugh,et al.  Hospital Quality for Acute Myocardial Infarction Correlation Among Process Measures and Relationship With Short-term Mortality. , 2006, Neurosurgery.

[6]  A. Faustini,et al.  Profiling hospital performance to monitor the quality of care: the case of COPD , 2009, European Respiratory Journal.

[7]  P. Calverley,et al.  COPD performance measures: missing opportunities for improving care. , 2010, Chest.

[8]  W. Bailey,et al.  Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. , 2008, Thorax.

[9]  E. McGlynn,et al.  The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. , 2006, Chest.

[10]  Janet M. Corrigan,et al.  Leadership by example : coordinating government roles in improving health care quality , 2003 .

[11]  S. Normand,et al.  Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.

[12]  M. Pearson,et al.  Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease , 2002, Thorax.

[13]  F. Harrell,et al.  USING FULL PROBABILITY MODELS TO COMPUTE PROBABILITIES OF ACTUAL INTEREST TO DECISION MAKERS , 2001, International Journal of Technology Assessment in Health Care.

[14]  P. Lindenauer,et al.  Quality of Care for Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2006, Annals of Internal Medicine.

[15]  James E. Johnson,et al.  Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD , 2007, Thorax.

[16]  S. Normand,et al.  Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement. , 2007, Health affairs.

[17]  G. Diette,et al.  In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. , 2003, Archives of internal medicine.

[18]  Sharon-Lise T. Normand,et al.  Statistical and Clinical Aspects of Hospital Outcomes Profiling , 2007, 0710.4622.

[19]  S. Normand,et al.  Comparison of Hospital Risk-Standardized Mortality Rates Calculated by Using In-Hospital and 30-Day Models: An Observational Study With Implications for Hospital Profiling , 2012, Annals of Internal Medicine.

[20]  M. Yigla,et al.  Predictors of long‐term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease , 2008, Respirology.

[21]  Harlan M Krumholz,et al.  An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure , 2006, Circulation.

[22]  Harlan M. Krumholz,et al.  An Administrative Claims Model for Profiling Hospital 30-Day Mortality Rates for Pneumonia Patients , 2011, PloS one.

[23]  A. Faustini,et al.  The impact on risk-factor analysis of different mortality outcomes in COPD patients , 2008, European Respiratory Journal.